US Patent 7892546 Anti-CXCR4 antibodies
Patent 7892546 was granted and assigned to Eli Lilly and Company on February, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7892546 Anti-CXCR4 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
